Find your strongest 510(k) predicate in minutes.
AI-powered predicate analysis backed by 91K+ indexed 510(k) summaries, the full openFDA clearance history, FDA guidance documents, and semantic search. FDA Best Practices compliance scoring on every candidate.
No account required for the first analysis. Results in minutes.
DEVICE · K-XXXXXX
Predicate Intelligence Report
Generated for review · 35+ pages
Executive Summary
- Recommended predicate
- Pathway decision
Selection Strategy
- 91K+ semantic search
- Lineage 3 levels deep
Technical Evidence
- 8-dimension SE matrix
- Best Practices scorecard
Submission Framework
- Pathway + PCCP + eSTAR
- Action checklist
Built for health-tech teams navigating FDA clearance.
Startup founders
First 510(k) submission? Get expert-level predicate analysis in minutes, without a multi-week, $5,000+ engagement. Understand your regulatory landscape before you spend.
Regulatory affairs
Validate predicate selection with data-driven scoring, FDA Best Practices compliance, and a drafted 510(k) Summary narrative to adapt against your evidence, whether you're doing the work in-house or working with an outside consultant. Save hours of manual research either way.
Consultants & advisors
Deliver predicate analysis to your clients faster. Use Keenr as your research engine while you focus on strategy and client relationships. Partner plans add editable Word export and volume pricing.
Investors & diligence teams
Evaluate regulatory feasibility in minutes. Understand pathway risk, predicate strength, and competitive landscape before committing capital. Same report your portfolio companies will use, ready to share.
From device description to regulatory strategy in 4 steps.
Describe your device
Enter your device description and intended use. Run Keenr's one-click input check to flag vague or contradictory wording before it costs you a report.
We search 91K+ clearances
Hybrid search combines openFDA structured data with semantic similarity across the full 510(k) summary corpus. Cross-code discovery finds predicates keyword search misses — even in product codes with zero prior clearances.
AI evaluates each candidate
Our reasoning loop scores every candidate against FDA's 4 Best Practices criteria, runs an 8-dimension substantial equivalence comparison aligned with eSTAR, and traces predicate lineage chains up to 3 levels deep.
Get your report
Download a 35+ page branded PDF with predicate recommendation, lineage chains, pathway decision, and a drafted 510(k) Summary narrative formatted per FDA guidance Section VI. AI/ML reports run longer with PCCP, foundation model, and algorithm change sections.
Not just a database search.
Most predicate tools sort by date. We rank by relevance to your device.
FDA Best Practices aligned
Every predicate is scored against FDA's September 2023 guidance: well-established methods, safety performance, no unmitigated issues, no design-related recalls. You get a compliance scorecard, not just a list.
Semantic search across 91K+ submissions
We don't just match product codes. Our vector database embeds every 510(k) summary and finds semantically similar devices across ALL product codes — catching predicates keyword search misses entirely.
Predicate lineage chains
See who your predicate cited as THEIR predicate, and who they cited. Trace citation chains 3 levels deep from actual 510(k) summary text. Understand chain depth and risk before FDA asks.
AI/ML device depth, built in
Every AI/ML report includes software taxonomy (SaMD vs SiMD, locked vs adaptive), IMDRF risk classification, PCCP requirement assessment against 80+ cleared precedents, a weekly-refreshed foundation-model disclosure tracker, and algorithm-change precedents drawn from real cleared filings — grounded in FDA's January 2025 AI-Enabled Device Software Functions guidance.
Regulatory pathway decision engine
Not just "510(k)" — we evaluate Traditional, Special, Abbreviated, De Novo, Breakthrough Device, and PMA pathways with specific eligibility reasoning, PCCP assessment, and pre-submission meeting recommendations.
Drafted 510(k) Summary narrative
Get a multi-paragraph predicate selection narrative formatted per FDA guidance Section VI. Explains predicate choice, best practices compliance, and substantial equivalence basis. Adapt it against your evidence.
What this report does for your submission.
Eleven research outputs across the five areas of a 510(k) — plus two more when your device is AI/ML. Early-stage strategy your team, your consultant, or your institutional partner can build a submission around.
Pathway decision
Accelerates Pathway Planning
A recommended pathway, with the reasoning shown.
Detail +Detail −
Recommends a regulatory pathway with the reasoning behind it, comparing Traditional, Special, and Abbreviated 510(k) against De Novo, Breakthrough Device, and PMA for your device profile. Gives your team or consultant a defensible starting point.
Tests Product Classification
An outright code call: one, a pair, or no clean fit.
Detail +Detail −
Tests whether the product code you're considering fits your device's technical features, surfaces adjacent codes worth a closer look, and makes an outright call: file under one code, a pair, or flag that no code fits cleanly yet. Reduces the risk of building a submission on a misclassified code.
Ranked candidates
- K183927 0.94
- K201432 0.93
- K198567 0.89
Strengthens Predicate Selection
A scored shortlist — every candidate’s scorecard visible.
Detail +Detail −
Ranks predicate candidates on a 100-point scale using FDA's September 2023 Best Practices criteria. Produces a scored shortlist of the most defensible substantial-equivalence options, with the full scorecard visible for every candidate, ready for a regulatory consultant's review.
Strengthens Safety Vetting
Two safety lenses: your whole product code, then each candidate.
Detail +Detail −
Two safety lenses: aggregate adverse-event volume across your entire product code, plus a per-candidate MAUDE and recall deep dive linked straight into FDA's database. Surfaces safety patterns worth investigating before your team or consultant builds the substantial-equivalence argument.
Uncovers Competitive Insights
The clearance landscape, quantified.
Detail +Detail −
Quantifies the clearance landscape for your product code (volume, average review time, recent activity), and tracks semantically adjacent codes for competitive devices a keyword search might miss.
eSTAR mapping
- §4 Device Description drafted
- §5 Substantial Equivalence drafted
- §9 Software Documentation outlined
- §12 Performance Testing outlined
Reduces Drafting Time
A Section VI narrative draft, ready to adapt.
Detail +Detail −
Produces a draft Predicate Selection Narrative aligned with FDA Section VI requirements. A working draft your team or consultant can adapt, not a finished submission.
Maps to eSTAR Template
Analysis routed to the eSTAR sections that need it.
Detail +Detail −
Routes the device analysis to mandatory eSTAR sections: Section 4 (Device Description), Section 5 (Substantial Equivalence), Section 9 (Software Documentation), Section 12 (Performance Testing). Cuts the translation work between research and template inputs.
Drafts Your Pre-Sub Question Packet
Q-Sub questions drafted before you meet FDA.
Detail +Detail −
When a pre-submission meeting is warranted, drafts device-specific Q-Sub questions with a similarities-and-differences scaffold and a high-level testing approach — a starting point your team or consultant can refine before meeting FDA.
Compliance read
- Software documentation ENHANCED
- IDE determination ASSESSED
- Human factors FLAGGED
- Bench testing STANDARDS-ANNOTATED
Clarifies Compliance Needs
Documentation level and IDE flags, called early.
Detail +Detail −
Assesses whether your system likely requires the "Enhanced" software documentation level under FDA's guidance, and outlines the design specs, traceability matrices, and cybersecurity protocols reviewers typically expect. When clinical data is likely needed, it also flags whether an Investigational Device Exemption (IDE) is in play and at what risk category.
Informs Engineering Investment
A prioritized launch checklist.
Detail +Detail −
Produces a prioritized launch checklist: Pre-Submission meeting timing, multi-site validation with demographic stratification, human factors testing. Helps focus engineering and clinical investment on the work most likely to matter at FDA review.
Consolidates Regulatory Research
Your specialty panel’s guidance, linked in one place.
Detail +Detail −
Compiles the FDA guidance mapped to your device's medical-specialty panel — plus cross-cutting AI/ML, digital-health, and labeling guidance — each with a direct link and the specific requirements it raises for your submission.
PCCP intelligence
- Training data
- Model retraining
- Performance specs
- Deployment
Informs PCCP Strategy
A PCCP outline to develop with FDA.
Detail +Detail −
Drafts a Predetermined Change Control Plan (PCCP) outline your team or consultant can develop with FDA. Reduces the risk of the cycle where every post-market algorithm update triggers a new submission.
Anticipates AI/ML Review Risks
The failure patterns that trigger FDA questions.
Detail +Detail −
Surfaces recurring AI/ML failure patterns from cleared devices, with suggested mitigation areas for acceptance criteria and demographic dataset tracking. Anticipates the issues that most often trigger FDA additional-information requests.
Pay per report. Or by the bundle.
$499 per single report, with 3-pack and 10-pack bundles for teams running multiple devices. Partner plans add editable Word export and volume pricing.
Built on FDA guidance.
The tool's predicate selection methodology is anchored in FDA's September 2023 "Best Practices for Selecting a Predicate Device" guidance, supported by the documents listed below. Every report cites the specific guidance informing each section.
- Primary Methodology Reference
Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission
September 2023PRIMARY METHODOLOGY REFERENCE. Defines the four best-practice criteria for predicate selection — (1) well-established methods, (2) postmarket safety performance, (3) no unmitigated safety issues, (4) no design-related recall — that drive the FDA Best Practices Scorecard in every report this tool generates.
Open on FDA.gov →
-
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
July 2014Foundational SE-determination framework that the 2023 Best Practices guidance sits inside. Defines how indications, technological characteristics, and performance data combine to demonstrate substantial equivalence — the structure the SE Comparison table in this report follows.
Open on FDA.gov →
-
De Novo Classification Process (Evaluation of Automatic Class III Designation)
October 2021Pathway for novel, low-to-moderate risk devices without an adequate predicate.
Open on FDA.gov →
-
Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
January 2025Lifecycle-management expectations and submission content for AI-enabled devices.
Open on FDA.gov →
-
Marketing Submission Recommendations for a Predetermined Change Control Plan for AI/ML-Enabled Device Software Functions
December 2024PCCP framework — how to pre-authorize planned algorithm changes without re-submitting.
Open on FDA.gov →
-
Breakthrough Devices Program
September 2023Expedited development and review for devices addressing life-threatening or irreversibly debilitating conditions.
Open on FDA.gov →
-
Clinical Decision Support Software
September 2022Criteria for when CDS software is / is not a regulated device under 21st Century Cures.
Open on FDA.gov →
-
Software as a Medical Device (SaMD): Clinical Evaluation
December 2017Framework for generating clinical evidence to support SaMD.
Open on FDA.gov →
-
Software as a Medical Device (SaMD): Possible Framework for Risk Categorization and Corresponding Considerations
September 2014 (IMDRF)IMDRF risk categorization (I–IV) referenced in the AI/ML assessment section.
Open on FDA.gov →
-
eSTAR Program
OngoingElectronic submission template mandatory for most 510(k) submissions. The eSTAR Mapping section aligns each analysis area to the corresponding eSTAR section.
Open on FDA.gov →
Frequently asked questions.
What is a 510(k) predicate device?
How accurate is the predicate recommendation?
What data sources do you use?
Can I use this for AI/ML medical devices?
How is this different from searching openFDA myself?
Is the report suitable for my 510(k) submission?
What does a Keenr report cost, and are there volume discounts?
Do you offer consultant or multi-report plans?
What if my device description isn’t good enough?
What if no predicate exists for my device?
How often is the database updated?
See the real thing.
These are pages from the actual sample report, not mockups. The full 35+ page PDF is one email away.
Ready to find your predicate?
Get your 35+ page Predicate Intelligence Report in minutes.
This tool is for informational and research purposes only and does not constitute regulatory, legal, or professional advice. All analysis is AI-generated and should be reviewed by a qualified regulatory professional. Data sourced from openFDA and publicly available 510(k) clearance packages. Terms · Privacy · FDA.gov